Dysregulated interleukin networks drive immune heterogeneity in Alzheimer’s disease: an immunogenomic approach to subgroup classification and predictive modeling
Abstract Background Alzheimer’s Disease (AD) is marked by intricate immunological alterations, including the dysregulation of interleukin signaling. This study investigates the differential expression and potential roles of interleukins and their receptors in AD patients. Methods We analyzed the GSE...
Saved in:
| Main Authors: | Bin Zhang, Binglei Xu, Ruoxian Zhang, Baoying Gong, Jianwen Guo |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-04-01
|
| Series: | BMC Neurology |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12883-025-04155-y |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Deciphering the integrated immunogenomic landscape of colorectal cancer: insights from Mendelian randomization and immune-stratified molecular subtyping
by: Ke-Jie He, et al.
Published: (2025-03-01) -
CD28+ CD45RA− CD8br AC mediated the effects of Interleukin- 6 on Alzheimer's disease: A Mendelian Randomization Study
by: Rui Xu, et al.
Published: (2025-05-01) -
A large-scale multi-centre study characterising atrophy heterogeneity in Alzheimer’s disease
by: Vikram Venkatraghavan, et al.
Published: (2025-09-01) -
New areas of the pharmacotherapy of rheumatic diseases are inhibition of interleukin-6 and interleukin-17
by: Evgeny Lvovich Nasonov
Published: (2013-10-01) -
Chromone hybrids as interleukin-6 and acetylcholinesterase inhibitor for treatment of Alzheimer's disease: Design, docking, synthesis and evaluation
by: Shivam Mishra, et al.
Published: (2024-12-01)